Kinetics and determinants of the changes of CC16, a lung secretory protein in a rat model of toxic lung injury

Clinical Toxicology

Volumn 46, Issue 3, 2008, Pages 230-238

  Hantson, Philippe ^a   Bernard, Alfred ^a   Hermans, Cedric ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Broncheo alveolar lavage fluid; Clara cell 16 kDa protein; Renal Failure; Toxic lung injury

Indexed keywords

4 IPOMEANOL; ALBUMIN; ANTU; CLARA CELL PROTEIN; CREATININE; CYSTATIN C; PARAQUAT; PROTEIN CC16; SODIUM CHROMATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS INJURY; BRONCHUS SECRETION; CLARA CELL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; KIDNEY INJURY; LUNG INJURY; LUNG LAVAGE; LUNG TOXICITY; NONHUMAN; PROTEIN SECRETION; RAT;

ALBUMINS; ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CALIBRATION; CYSTATINS; FEMALE; KINETICS; LUNG DISEASES; RATS; RATS, SPRAGUE-DAWLEY; UTEROGLOBIN;

RATTUS;

EID: 40849135674     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701449448     Document Type: Article

References (52)

1. Hermans C, Bernard A. Pneumoproteinaemia: A new perspective in the assessment of lung disorders. Eur Respir J 1998; 11: 801-803.
2. Singh G, Singh J, Katyal SL, Brown WE, Kramps JA, Paradis IL, Dauber JH, Macpherson TA, Squeglia N. Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein. J Histochem Cytochem 1988; 36:73-80.
3. Singh G, Katyal SL. An immunologic study of the secretory products of rat Clara cells. J Histochem Cytochem 1984; 32:49-54.
4. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 1992; 5:1231-1238.
5. Shijubo N, Itoh Y, Yamaguchi T, Shibuya Y, Morita Y, Hirasawa M, Okutani R, Kawai T, Abe S. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J 1997; 10:1108-1114.
6. Halatek T, Hermans C, Broeckaert F, Wattiez R, Wiedig M, Toubeau G, Falmagne P, Bernard A. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Respir J 1998; 11:726-733.
7. Bernard A, Thielemans N, Lauwerys R, Vandeleene B, Lambert AE. The renal handling of protein 1 (Clara cell protein): effect of age, sex and renal dysfunction. Contrib Nephrol 1993; 101:66-70.
8. Bernard A, Roels H, Buchet JP, Lauwerys R. Decrease of serum Clara cell protein in smokers [letter]. Lancet 1992; 339:1620.
9. Bernard AM, Roels HA, Buchet JP, Lauwerys RR. Serum Clara cell protein: An indicator of bronchial cell dysfunction caused by tobacco smoking. Environ Res 1994; 66:96-104.
10. Lumsden AB, McLean A, Lamb D. Goblet and Clara cells of human distal airways: Evidence for smoking induced changes in their numbers. Thorax 1984; 39:844-849.
11. Hermans C, Osman A, Nyberg BI, Peterson C, Bernard A. Determinants of Clara cell protein (CC16) concentration in serum: A reasessment with two different immunoassays. Clin Chim Acta 1998; 272:101-110.
12. Lesur O, Bernard A, Arsalane K, Lauwerys R, Begin R, Cantin A, Lane D. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152:290-297.
13. Bernard A, Hermans C, Van Houte G. Transient increase of serum Clara cell protein (CC16) after exposure to smoke. Occup Environ Med 1997; 54:63-65.
14. Hermans C, Petrek M, Kolek V, Pieters T, Lambert M, Bernard A. Serum Clara cell protein (CC16) correlates with chest radiographic abnormalities of sarcoidosis. Am J Respir Crit Care Med 1997; 155:A981.
15. Kabanda A, Jadoul M, Pochet JM, Lauwerys R, van Ypersele de Strihou C, Bernard A. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int 1994; 45:1689-1696.
16. Doster AR, Farrell RL, Wilson BJ. An ultrastructural study of bronchiolar lesions in rats induced by 4-ipomeanol, a product from mold-damaged sweet potatoes. Am J Pathol 1983; 111:56-61.
17. Sabo JP, Kimmel EC, Diamond L. Effects of the Clara cell toxin, 4-ipomeanol, on pulmonary function in rats. J Appl Physiol 1983; 54:337-344.
18. Day BJ, Carlson GP, DeNicola D. B. gamma-Glutamyltranspeptidase in rat bronchoalveolar lavage fluid as a probe of 4-ipomeanol and alpha- naphthylthiourea-induced pneumotoxicity. J Pharmacol Methods 1990; 24:1-8.
19. Verschoyle RD, Philpot RM, Wolf CR, Dinsdale D. CYP4B1 activates 4-ipomeanol in rat lung. Toxicol Appl Pharmacol 1993; 123:193-198.
20. Newton PE, Latendresse JR, Mattie DR, Pfledderer C. Alterations in alveolar clearance after 4-ipomeanol-induced necrosis of Clara and ciliated cells in the terminal bronchiole of the rat. Toxicol Appl Pharmacol 1985; 80:534-541.
21. Boyd MR, Neal RA. Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin, alpha-naphthylthiourea (ANTU). Drug Metab Dispos 1976; 4:314-322.
22. Cunningham AL, Hurley JV. Alpha-naphthyl-thiourea-induced pulmonary oedema in the rat: a topographical and electron-microscope study. J Pathol 1972; 106:25-35.
23. Viau C, Bernard A, Ouled A, Lauwerys R. Determination of rat beta 2-microglobulin in urine and in serum. II. Application of its urinary measurement to selected nephrotoxicity models. J Appl Toxicol 1986; 6:191-195.
24. Girolami JP, Orfila C, Pecher C, Cabos Boutot G, Bascands JL, Moatti JP, Adam A, Colle A. Inverse relationship between renal and urinary kallikrein during chromate-induced acute renal failure in rat: Urinary kallikrein excretion as a possible recovery index. Biol Chem Hoppe Seyler 1989; 370:1305-1313.
25. Smith P, Heath D. Paraquat. CRC Crit Rev Toxicol 1976; 4:411-445.
26. Smith P, Heath D. The pathology of the lung in paraquat poisoning. J Clin Pathol Suppl R Coll Pathol 1975; 9:81-93.
27. Smith P, Heath D. The ultrastructure and time sequence of the early stages of paraquat lung in rats. J Pathol 1974; 114:177-184.
28. Smith P, Heath D, Kay JM. The pathogenesis and structure of paraquat-induced pulmonary fibrosis in rats. J Pathol 1974; 114:57-67.
29. Hampson EC, Eyles DW, Pond SM. Effects of paraquat on canine bronchoalveolar lavage fluid. Toxicol Appl Pharmacol 1989; 98:206-215.
30. Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A. Structure and expression of the human cystatin C gene. Biochem J 1990; 268:287-294.
31. Bernard A, Lauwerys R, Noel A, Vandeleene B, Lambert A. Determination by latex immunoassay of protein 1 in normal and pathological urine. Clin Chim Acta 1991; 201:231-245.
32. Halatek T, Hermans C, Wattiez R, Wiedig M, Toubeau G, Falmagne P, Bernard A. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Respir J 1998; 11:726-733.
33. Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, De Backer WA, Lauwerys R, Flower RJ, Bernard A. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 1995; 8:1647-1653.
34. Hermans C, Bernard A. Lung epithelium specific proteins : characteristics and potential applications as markers. State of the art. Am J Respir Crit Care Med 1999; 159:646-678.
35. Dierynck I, Bernard A, Roels H, De Ley M. Potent inhibition of both interferon-gamma production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol 1995; 12:205-210.
36. Guy J, Dhanireddy R, Mukherjee AB. Surfactant-producing rabbit pulmonary alveolar type II cells synthetize and secrete an antiinflammatory protein, uteroglobulin. Biochem Biophys Res Commun 1992; 189:662-669.
37. Bernard A, Dumont X, Roels H, Lauwerys R, Dierynck I, De Ley M, Stroobant V, de Hoffmann E. The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. Clin Chim Acta 1993; 223:189-191.
38. Itoh Y, Ishii S, Okutani R, Asano Y, Kawai T. Protein 1: Its purification and application in clinical medicine. J Clin Lab Anal 1993; 7:394-400.
39. Shijubo N, Itoh Y, Yamaguchi T, Shibuya Y, Morita Y, Hirasawa M, Okutani R, Kawai T, Abe S. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J 1997; 10:1108-1114.
40. Lesur O, Bernard A, Arsalane K, Lauwerys R, Begin R, Cantin A, Lane D. Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152:290-297.
41. Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, De Backer WA, Lauwerys R, Flower RJ, Bernard A. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 1995; 8:1647-1653.
42. Lesur O, Langevin S, Berthiaume Y, Legare M, Skrobik Y, Bellemare JF, Levy B, Fortier Y, Lauzier F, Bravo G, Nickmilder M, Rousseau E, Bernard A, Critical Care Research Group of the Quebec Respiratory Health Network. Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome. Intensive Care Med 2006; 32:1167-1174.
43. Hermans C, Knoops B, Wiedig M, Arsalane K, Toubeau G, Falmagne P, Bernard A. Clara cell protein (CC16) in experimental lung injury: assessment as marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 1999; 13:1014-1021.
44. Hantson P, Weynand B, Doyle I, Bernard A, Hermans C. Pneumoproteins as markers of paraquat kung injury: A clinical case. J Legl Forensic Med 2008; 15:48-52.
45. Bell DY, Haseman JA, Spock A, McLennan G, Hook GE. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis 1981; 124:72-79.
46. Jones KP, Edwards JH, Reynolds SP, Peters TJ, Davies BH. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease. Eur Respir J 1990; 3:152-156.
47. Taylor AE, Gaar KAJ. Estimation of equivalent pore radii of pulmonary capillary and alveolar membranes. Am J Physiol 1970; 218:1133-1140.
48. Conhaim RL, Eaton A, Staub NC, Heath TD. Equivalent pore estimate for the alveolar-airway barrier in isolated dog lung. J Appl Physiol 1988; 64:1134-1142.
49. Holter JF, Weiland JE, Pacht ER, Gadek JE, Davis WB. Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J Clin Invest 1986; 78:1513-1522.
50. Doyle IR, Hermans C, Bernard A, Nicholas TE, Bersten AD. Clearance of Clara cell secretory protein and surfactant proteins A and B from blood in acute respiratory failure. Am J Respir Crit Care Med 1999; 158:1528-1535.
51. Kabanda A, Goffin E, Bernard A, Lauwerys R, van Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 1995; 48:1946-1952.
52. Hermans C, Dong P, Robin M, Jadoul M, Bernard A, Bersten AD, Doyle IR. Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16. Biomarkers 2003; 8:461-471.